skip to Main Content

Home
Team
Technology
Pipeline
News
Partners
Supports
Contact

Open Mobile Menu

News

WILCO startup cluster

December 5, 2018
tokyonne
News

HEPHAISTOS-Pharma was selected by WILCO startup cluster to obtain capital loans and increase our own funds.

Share This

Tweet
Share
Share
Email

Related Posts

“Golden Ticket” award for HEPHAISTOS from Amgen France and BioLabs Hôtel-Dieu

December 10th, 2024 HEPHAISTOS-Pharma has the honor to be a winner of a Golden Ticket…

Bio-Spring Europe 2024

Frederic CAROFF will attend BIO Europe Spring in Barcelona

Our CEO, Frederic CAROFF will be attending BIO-Europe Spring 2024 in Barcelona from March 18th…

HEPHAISTOS secures €10.3 M to reach the clinical stage

HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a total of €10.3 million from…

next post: European Grant

Home
Team
Technology
Pipeline
News
Partners
Supports
Contact

2025 © HEPHAITOS PHARMA. ALL RIGHTS RESERVED. | Privacy statement

Back To Top